Furthermore, Yoon et al. [92] revealed that the PGD2/PTGDR2 signaling pathway inhibits epithelial–mesenchymal transition (EMT) and reduces lung inflammation in pulmonary fibrosis. This evidence concerns the gene PTGDR2 and pulmonary fibrosis.